Circio Holding ASA announced as a result of this new strategic focus and after discussions with the Nomination Committee, the three Directors Bente-Lill Romøren, Sonia Quaratino and Raphael Clynes have tendered their resignations from Circio's Board. In parallel, the management team has been reorganized with VP and Head of Clinical Development, Margrethe Sørgaard, moving on to take up a new external role. Following the resignations, Circio´s Board will, effective 17 October 2023 and until the 2024 Annual General Meeting, be comprised of four Directors: Damian Marron (Chairman), Diane Mellet, Robert Burns and Thomas Falck.

Circio's management team will consist of five members: Erik D Wiklund (CEO), Lubor Gaal (CFO), Victor Levitsky (CSO), Thomas B Hansen (VP & Head of Research) and Ola Melin (VP & Head of Manufacturing).